participate in a clinical trial
Clinical trials help doctors test new treatments to make sure they are safe and actually work. These studies may look at new medicines, vaccines, or medical devices and compare them to what is used today to see which helps people more and causes fewer side effects. If a new treatment proves safe and helpful, it can become the new standard of care — giving patients better options and improving health for the future. Consider participating in a Clinical trial!
Participation Benefits
- Free medication & medical assessments
- Access to additional therapeutic options
- No health insurance necessary
- Compensation for time and travel
Current Enrolling Studies
Listed are our current enrolling studies. Please complete the form below and a member of our study staff will contact you with more information. If you do not fit a current study , we encourage you to still fill out a form and you will be contacted for future studies.
PLEASE NOTE ALL INFORMATION IS CONFIDENTIAL AND WILL ONLY BE VIEWED BY VAST CLINICAL RESEARCH PERSONNEL
Atopic Dermatitis (Eczema) – This study will evaluate the study medication’s safety & effectiveness in treating Atopic Dermatitis.
- Ages: 18+
- Have a diagnosis of Atopic Dermatitis for at least 1 year
- Other criteria to be assessed
Hidradenitis Suppurativa – This study will evaluate the study medication’s safety & effectiveness in treating Hidradenitis Suppurativa.
- Ages: 18+
- Have a diagnosis of Hidradenitis Suppurativa for at least 1 year
- Other criteria to be assessed
Diabetic Foot Ulcer – This study will evaluate the usage of an allograft to treat non-healing diabetic foot ulcers.
- Ages: 18+
- Have Type 1 or Type 2 diabetes
- Have a Diabetic Foot Ulcer
- Other criteria to be assessed.
Influenza/COVID – This study will evaluate the performance of a new influenza and COVID testing kit.
- Ages: Patient is two (2) years or older at time of enrollment.
- Patient is exhibiting 2 or more signs/symptoms of a respiratory infection including, but not limited to, fever, muscle or body
aches, sore throat, cough, congestion or runny nose, or headache. - Other criteria to be assessed.
Pelvic/Ovarian Mass (Women ONLY) – This study will evaluate the performance of a scoring system used to assess ovarian or pelvic abnormalities.
- Ages: 18+
- Have visible ovarian or pelvic abnormality on ultrasound (e.g. ovarian cyst or a simple, complex or a solid ovarian/pelvic mass)
- Other criteria to be assessed.
Syphilis (STD Testing) – This study will evaluate the performance of a new syphilis testing kit.
- Ages: 16+
- Patients undergoing routine syphilis testing (asymptomatic at risk, suspected with symptoms, prior history of syphilis, high risk for syphilis) or previously diagnosed with syphilis through a test performed in an accredited laboratory.
- Other criteria to be assessed.
Pneumococcal Vaccine – This study will evaluate the safety and immunogenicity of a new pneumococcal vaccine in young newborns, 42 to 89 DAYS old.
- Ages: 42 to 89 DAYS old
- Healthy as determined by medical evaluation
- Born at full term (≥37 weeks) and with a birth weight ≥2.5 kg or born after 28 weeks through 36 weeks and with a birth weight ≥1.5 kg.
- Other criteria to be assessed.